Skip to main content

Table 3 Details of CD4 count categories

From: Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis

Study name Study type Period Diseases Location Study size Follow up CD4 (group 1) cells/mm3 CD4(group 2) cells/mm3 RR 95%
Deti, 2010 Cohort 2004-2008 CRF France 2613 3.4 < 200 > 500 4.04 2.3, 7.1
Deti, 2010 Cohort 2004-2008 CRF France 2613 3.4 200-500 > 500 1.33 0.81, 2.19
Franceschini, 2006 Cohort 2000-2002 ARF USA 705 3.0 < 200 > 200 4.70 2.5, 8.8
Ganesan, 2010 Cohort 1986-2008 CKD USA 4044 6.5 < = 200 > = 500 6.8 3.0, 15.5
Ganesan, 2010 Cohort 1986-2008 CKD USA 4044 6.5 201-349 > = 500 4.3 2.3, 8.1
Ganesan, 2010 Cohort 1986-2008 CKD USA 4044 6.5 350-499 > = 500 2.4 1.3, 4.6
Franey, 2009 Cohort 2004-2007 RI South Africa 2189 -- < 100 > 100 1.4 1.07, 1.82
Ibrahim, 2010 Cohort 1999-2008 ARF UK 2556 -- 201-350 > 350 1.56 0.97, 2.48
Ibrahim, 2010 Cohort 1999-2008 ARF UK 2556 -- 101-200 > 350 2.08 1.11, 3.91
Ibrahim, 2010 Cohort 1999-2008 ARF UK 2556 -- 51-100 > 350 6.38 3.18, 12.78
Ibrahim, 2010 Cohort 1999-2008 ARF UK 2556 -- 0-50 > 350 10.29 5.11, 20.98
Krawczyk, 2004 Cohort 1992-2002 CRF USA 6361 -- < 200 200-349 4.3 2.1, 8.7
Roe, 2008 Cohort 1998-2005 ARF UK 2274 8.0 < 100 > 200 6.75 2.5, 18.3
Roe, 2008 Cohort 1998-2005 ARF UK 2274 8.0 100-199 > 200 3.02 0.99, 9.13
Szczech, 2002 Cohort 1994-1999 RF USA 2057 4.5 < = 200 > 200 3.57 1.72, 7.14
Wei, Cohort 1993-1997 HIVAN USA 44 5.1 < = 100 > = 100 2.73 0.82, 9.14